Health Care REIT, Inc. 8-K
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 20, 2006
Health Care REIT, Inc.
(Exact name of registrant as specified in its charter)
         
Delaware   1-8923   34-1096634
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)
     
One SeaGate, Suite 1500, Toledo, Ohio   43604
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code (419) 247-2800
 
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 8.01 Other Events.
     Pursuant to Statement of Financial Accounting Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, certain assets of Health Care REIT, Inc. (the “Company”) are now classified as discontinued operations due to their sale during the nine months ended September 30, 2006 or their classification as held for sale at September 30, 2006. As a result, the Company is reclassifying in this Current Report its operations, including rental income, interest expense and provision for depreciation related to those assets for prior periods. In so doing, the Company is updating portions of Items 6, 7, 7A and 8 of its Annual Report on Form 10-K for the year ended December 31, 2005, including the information regarding discontinued operations contained in “Item 6 — Selected Financial Data,” “Item 7 — Management’s Discussion and Analysis of Financial Condition and Results of Operations — Results of Operations,” “Item 7A — Quantitative and Qualitative Disclosures About Market Risk” and “Item 8 — Financial Statements and Supplementary Data.”
     In addition, the Company is updating “Item 7 — Management’s Discussion and Analysis of Financial Condition and Results of Operations — Non-GAAP Financial Measures” to include presentations of EBITDA and Adjusted EBITDA consistent with its most recent Quarterly Report on Form 10-Q and “Item 7A — Quantitative and Qualitative Disclosures About Market Risk” to provide additional information regarding its swap agreements and interest rate sensitivity.
     All other information contained in the Form 10-K and the other portions of Items 6, 7 and 8 have not been updated or modified (with the exception of certain minor changes to Items 7 and 8 to reflect proper cross-references). For more recent information regarding the Company, please see the Company’s Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other reports and information filed with or furnished to the Securities and Exchange Commission since March 10, 2006. Additionally, the Company is including, for informational purposes, Financial Statement Schedules III and IV, which are unchanged from Item 15 of the Form 10-K. The foregoing items are attached as Exhibit 99.1 to this Current Report. The application of Statement No. 144 had no effect on net income available to common stockholders.
Item 9.01 Financial Statements and Exhibits.
(a) Financial Statements of Business Acquired.
None.
(b) Pro Forma Financial Information.
None.
(c) Exhibits.
23.1   Consent of Ernst & Young LLP, independent registered public accounting firm
 
99.1   Selected Financial Data
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Quantitative and Qualitative Disclosures About Market Risk
Financial Statements and Supplementary Data
Schedule III
Schedule IV
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant had duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
         
  HEALTH CARE REIT, INC.
 
 
  By:   /s/ GEORGE L. CHAPMAN    
    George L. Chapman   
       
 
Its: Chairman of the Board and Chief Executive Officer
Dated: October 20, 2006